Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 2
1953 1
1954 4
1998 1
2001 1
2002 3
2003 1
2004 1
2005 1
2006 2
2007 1
2008 1
2009 2
2010 2
2011 5
2012 2
2013 2
2014 1
2015 6
2016 2
2017 6
2018 2
2019 7
2020 6
2021 8
2022 1
2023 4
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for soucek l
Search for Souceck L instead (2 results)
Drugging the 'undruggable' cancer targets.
Dang CV, Reddy EP, Shokat KM, Soucek L. Dang CV, et al. Among authors: soucek l. Nat Rev Cancer. 2017 Aug;17(8):502-508. doi: 10.1038/nrc.2017.36. Epub 2017 Jun 23. Nat Rev Cancer. 2017. PMID: 28643779 Free PMC article. Review.
Finding MYCure.
Beaulieu ME, Soucek L. Beaulieu ME, et al. Among authors: soucek l. Mol Cell Oncol. 2019 Jun 20;6(5):e1618178. doi: 10.1080/23723556.2019.1618178. eCollection 2019. Mol Cell Oncol. 2019. PMID: 31528695 Free PMC article.
MYC in cancer: from undruggable target to clinical trials.
Whitfield JR, Soucek L. Whitfield JR, et al. Among authors: soucek l. Nat Rev Drug Discov. 2025 Jun;24(6):445-457. doi: 10.1038/s41573-025-01143-2. Epub 2025 Feb 19. Nat Rev Drug Discov. 2025. PMID: 39972241 Review.
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.
Beaulieu ME, Jauset T, Massó-Vallés D, Martínez-Martín S, Rahl P, Maltais L, Zacarias-Fluck MF, Casacuberta-Serra S, Serrano Del Pozo E, Fiore C, Foradada L, Cano VC, Sánchez-Hervás M, Guenther M, Romero Sanz E, Oteo M, Tremblay C, Martín G, Letourneau D, Montagne M, Morcillo Alonso MÁ, Whitfield JR, Lavigne P, Soucek L. Beaulieu ME, et al. Among authors: soucek l. Sci Transl Med. 2019 Mar 20;11(484):eaar5012. doi: 10.1126/scitranslmed.aar5012. Sci Transl Med. 2019. PMID: 30894502 Free PMC article.
Editorial overview: Peptides in cancer.
Whitfield J, Soucek L. Whitfield J, et al. Among authors: soucek l. Curr Opin Pharmacol. 2019 Aug;47:iii-v. doi: 10.1016/j.coph.2019.06.001. Epub 2019 Jun 28. Curr Opin Pharmacol. 2019. PMID: 31257021 Free PMC article. No abstract available.
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors.
Román Alonso M, Grinyó-Escuer A, Duro-Sánchez S, Rius-Ruiz I, Bort-Brusca M, Escorihuela M, Maqueda-Marcos S, Pérez-Ramos S, Gago J, Nogales V, Espinosa-Bravo M, Peg V, Escrivá-de-Romaní S, Foradada L, Soucek L, Braña I, Galvao V, Martín-Lluesma S, Moessner E, Klein C, Garralda E, Saura C, Arribas J. Román Alonso M, et al. Among authors: soucek l. Nat Commun. 2024 Nov 18;15(1):9589. doi: 10.1038/s41467-024-53265-7. Nat Commun. 2024. PMID: 39557820 Free PMC article.
MYC targeting by OMO-103 in solid tumors: a phase 1 trial.
Garralda E, Beaulieu ME, Moreno V, Casacuberta-Serra S, Martínez-Martín S, Foradada L, Alonso G, Massó-Vallés D, López-Estévez S, Jauset T, Corral de la Fuente E, Doger B, Hernández T, Perez-Lopez R, Arqués O, Castillo Cano V, Morales J, Whitfield JR, Niewel M, Soucek L, Calvo E. Garralda E, et al. Among authors: soucek l. Nat Med. 2024 Mar;30(3):762-771. doi: 10.1038/s41591-024-02805-1. Epub 2024 Feb 6. Nat Med. 2024. PMID: 38321218 Free PMC article. Clinical Trial.
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate.
Bibbò S, Capone E, Lovato G, Ponziani S, Lamolinara A, Iezzi M, Lattanzio R, Mazzocco K, Morini M, Giansanti F, De Laurenzi V, Whitfield J, Iacobelli S, Ippoliti R, Beaulieu ME, Soucek L, Sala A, Sala G. Bibbò S, et al. Among authors: soucek l. J Control Release. 2024 Oct;374:171-180. doi: 10.1016/j.jconrel.2024.08.009. Epub 2024 Aug 14. J Control Release. 2024. PMID: 39128771 Free article.
MYC inhibitors in multiple myeloma.
Martínez-Martín S, Soucek L. Martínez-Martín S, et al. Among authors: soucek l. Cancer Drug Resist. 2021 Aug 13;4(4):842-865. doi: 10.20517/cdr.2021.55. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582389 Free PMC article. Review.
78 results